Abstract | BACKGROUND: METHODS: The upregulation of CST1 in gastric cancer was analyzed using RT-PCR (n=15), immnohistochemistry, and clinicopathological (n=77) analysis. CST1-siRNA was used for the suppression of CST1 gene expression and cathepsin proteolytic activity was assayed. RESULTS: CST1 was upregulated in cancerous lesions of gastric cancer tissues compared to noncancerous regions and clinicopathological analysis showed a significant correlation between high expression of CST1 and pTNM stage (p=0.044). In CST1-siRNA transfected cells, cell proliferation was reduced and the proteolytic activity of cathepsins was increased. CONCLUSIONS:
|
Authors | Eun Hwa Choi, Jong-Tae Kim, Joo Heon Kim, Soo-Young Kim, Eun Young Song, Jae Wha Kim, Seon-Young Kim, Young Il Yeom, Ik-Hwan Kim, Hee Gu Lee |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 406
Issue 1-2
Pg. 45-51
(Aug 2009)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 19463800
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cysteine Proteinase Inhibitors
- Salivary Cystatins
- Cathepsins
- Lithium Chloride
|
Topics |
- Cathepsins
(antagonists & inhibitors)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cysteine Proteinase Inhibitors
(genetics)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Immunohistochemistry
- Lithium Chloride
(pharmacology)
- Male
- Reverse Transcriptase Polymerase Chain Reaction
- Salivary Cystatins
(genetics)
- Stomach Neoplasms
(enzymology, genetics, metabolism, pathology)
- Up-Regulation
(drug effects)
|